These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19828825)

  • 1. Anaemia and renal dysfunction in chronic heart failure.
    van der Meer P; van Veldhuisen DJ
    Heart; 2009 Nov; 95(21):1808-12. PubMed ID: 19828825
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing chronic heart failure patient in chronic kidney disease.
    Abdo AS; Basu A; Geraci SA
    Am J Med; 2011 Jan; 124(1):26-8. PubMed ID: 20932501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers in chronic heart failure.
    Gheorghiade M; Colucci WS; Swedberg K
    Circulation; 2003 Apr; 107(12):1570-5. PubMed ID: 12668487
    [No Abstract]   [Full Text] [Related]  

  • 4. Inadequate treatment of congestive heart failure in dialysis patients.
    Bouchard J; Madore F
    Semin Dial; 2007; 20(5):383-6. PubMed ID: 17897240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Cardicor as first-line therapy in heart failure : CiBis iii.
    Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
    [No Abstract]   [Full Text] [Related]  

  • 6. Congestive heart failure-related anemia and a role for erythropoietin.
    Akram K; Pearlman BL
    Int J Cardiol; 2007 May; 117(3):296-305. PubMed ID: 16901559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure.
    van der Putten K; Braam B; Jie KE; Gaillard CA
    Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cardiorenal syndrome: an emerging renal disease].
    Fabbian F
    G Ital Nefrol; 2007; 24(2):108. PubMed ID: 17458823
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC
    Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract]   [Full Text] [Related]  

  • 10. Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well.
    Westenbrink BD; Visser FW; Voors AA; Smilde TD; Lipsic E; Navis G; Hillege HL; van Gilst WH; van Veldhuisen DJ
    Eur Heart J; 2007 Jan; 28(2):166-71. PubMed ID: 17158825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing patients with heart failure: the reality of clinical practice.
    Squire I
    Eur Heart J; 2005 Dec; 26(24):2611-3. PubMed ID: 16219652
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA; Gheorghiade M
    Heart Fail Clin; 2005 Apr; 1(1):77-93. PubMed ID: 17386836
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimal management of chronic heart failure in patients with chronic kidney disease.
    Zachariah D; Kalra PA; Kalra PR
    J Ren Care; 2009 Mar; 35(1):2-10. PubMed ID: 19200271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN; Mareev VIu; Skvortsov AA
    Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heart insufficiency: reflecting about the present . . . preparing for the future].
    Fonseca C; Brito D; Campêlo M
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():7-10. PubMed ID: 11409077
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypertension: which drugs to choose for patients with cardiovascular disease.
    Wexler R; Feldman D
    J Fam Pract; 2006 Apr; 55(4):291-8. PubMed ID: 16608667
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating patients with Chagas' cardiomyopathy with chronic heart failure in the contemporary era.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A
    Am Heart J; 2007 Nov; 154(5):e35; author reply e33. PubMed ID: 17967576
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic aims for atrial fibrillation in patients with heart failure].
    Lewalter T; Nitschmann S
    Internist (Berl); 2009 Jan; 50(1):101-3. PubMed ID: 19137270
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute and chronic management of atrial fibrillation in patients with late-stage CKD.
    Aronow WS
    Am J Kidney Dis; 2009 Apr; 53(4):701-10. PubMed ID: 19324248
    [No Abstract]   [Full Text] [Related]  

  • 20. [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection].
    van der Meer P; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(16):923-7. PubMed ID: 18561787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.